Safe to Stop Immunotherapy at 2 Years in Stable Lung Cancer
A large review has found no difference in overall survival with fixed-duration vs ongoing ICI treatment in progression-free non–small cell lung cancer.
Stay updated with breaking news from Jack West. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A large review has found no difference in overall survival with fixed-duration vs ongoing ICI treatment in progression-free non–small cell lung cancer.
Explore special articles published online first to coincide with presentations at ASCO American Society of Clinical Oncology's Annual Conference.
For patients with non–small cell lung cancer, sotorasib should not be used within 30 days of immune check point inhibitors (ICIs) because of increased toxicity, say French researchers.
Ulladulla had not played for two weeks due to a forfeit and the bye, while the Tigers are...
Cancer is an increasingly pressing issue in the Philippines. The disease is now the third leading cause of death in the country, with 250 Filipinos losing ...